Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study

Abstract Objectives This noninterventional, multidatabase, analytical cohort study explored whether vildagliptin is associated with an increased risk of specific safety events of interest, namely angioedema, foot ulcers, or skin lesions, adverse hepatic events, or serious infections compared with ot...

Full description

Bibliographic Details
Main Authors: Rachael Williams, Wolfgang Kothny, Carmen Serban, Sandra Lopez‐Leon, Frank de Vries, Raymond Schlienger
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
Online Access:https://doi.org/10.1002/edm2.84